Songli Wang

Key Laboratory Of Smart Drug Delivery
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Hydroxyl-Terminated Polyethylene Glycol Evades Human Pre-existing Anti-polyethylene Glycol Antibodies.

Hydroxyl-Terminated Polyethylene Glycol Evades Human Pre-existing Anti-polyethylene Glycol Antibodies.

Journal: ACS nano
Published: June 09, 2026

Engineered platelets-based drug delivery platform for targeted thrombolysis.

Engineered platelets-based drug delivery platform for targeted thrombolysis.

Journal: Acta pharmaceutica Sinica. B
Published: October 15, 2021

All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.

All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 14, 2021

A COVID-19 Rumor Dataset.

A COVID-19 Rumor Dataset.

Journal: Frontiers in psychology
Published: December 21, 2020

Factors Influencing the Immunogenicity and Immunotoxicity of Cyclic RGD Peptide-Modified Nanodrug Delivery Systems.

Factors Influencing the Immunogenicity and Immunotoxicity of Cyclic RGD Peptide-Modified Nanodrug Delivery Systems.

Journal: Molecular pharmaceutics
Published: August 14, 2020

Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.

Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 21, 2020

A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated.

A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated.

Journal: Acta pharmaceutica Sinica. B
Published: April 07, 2020

ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy.

ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 17, 2020

Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma.

Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 24, 2019

Co-delivery of paclitaxel and melittin by glycopeptide-modified lipodisks for synergistic anti-glioma therapy.

Co-delivery of paclitaxel and melittin by glycopeptide-modified lipodisks for synergistic anti-glioma therapy.

Journal: Nanoscale
Published: July 03, 2019

Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes.

Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 28, 2019

Liposomes with cyclic RGD peptide motif triggers acute immune response in mice.

Liposomes with cyclic RGD peptide motif triggers acute immune response in mice.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 04, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026